JDRF (Juvenile Diabetes Research Foundation)

Type 1 Diabetes (T1D) affects over 300,000 Canadians.

Photo: JDRF

Type 1 Diabetes (T1D) strikes both children and adults at any age. There is no cure for T1D and you do not outgrow it. Eight per cent of those with the disease are adults.

Photo: JDRF

A number of Investors Group (now IG Wealth Management) employees from their Québec General Office and several Québec region offices participated in the JDRF Ride for Diabetes in downtown Montréal.

Photo: JDRF

The JDRF Canadian Clinical Trial Network (JDRF CCTN) accelerates the testing of new technologies and treatments for individuals around the world living with type 1 diabetes (T1D).

Photo: JDRF

JDRF-funded researchers are committed to improving the lives of every person with type 1 diabetes (T1D) and to curing this disease.

Photo: JDRF

Funding Leading-Edge Diabetes Research

Type 1 diabetes (T1D) affects over 300,000 Canadians. It’s an autoimmune disease where the pancreas doesn’t produce insulin, the hormone that helps the body to control glucose (sugar) levels in the bloodstream. Without insulin, glucose builds up in the blood instead of being used for energy.  If left untreated, this results in significant complications and eventual death. There is no cure and people with T1D must inject themselves with artificial insulin; either by injection or pump, often several times a day.

For over 40 years, JDRF has been a global leader in the drive towards a cure for T1D, through both research funding and advocacy.  JDRF also provides support to living with T1D today to live healthier, easier, and safer lives.

JDRF’s goal is to progressively diminish the impact of this disease until there is world free from T1D. Power Corporation has supported the JDRF since 1988. 2021 marks the 100th anniversary of the discovery of insulin, and JDRF will be commemorating the milestone with a significant push towards accelerating research towards a cure.

The commitment and passion from the business community and from companies such as Power Corporation is fundamental to helping JDRF invest more money in finding a cure for type 1 diabetes research, and at a faster pace.
Dave Prowten
President and CEO
JDRF Canada



Canadians live with Type 1 Diabetes (T1D)


invested in T1D research in Canada in 2019


cutting edge projects and clinical trials supported in Canada


raised by the JDRF House ParT1D for a Cure in 2020 to accelerate research


See videos from JDRF on YouTube.